Beta & Early Access Agreement

Agreement Overview

Beta & Early Access Agreement

This Agreement governs participation in a designated pre-release program offered by EMPHOS Group Corporation (“EMPHOS,” “we,” “us,” or “our”). A program may relate to Aletheia, Heinrich, FieldLine PDF, or another EMPHOS product or feature identified in the invitation.

By accepting a program invitation or accessing a Beta Product after these terms have been made available to you, you agree to this Agreement and the applicable program terms. If you do not agree, do not access the Beta Product and contact us about the invitation.

A standard trial of a released product, including an offered FieldLine PDF 30-day trial, follows its product trial and licence terms. It is covered by this Beta Agreement only if it is expressly offered as part of a designated Beta Program. A beta feature within a released application is covered only to the extent identified in the program notice.

Section 1

Eligibility & Invitation

Participation is by invitation only. EMPHOS selects participants and determines the scope of each program. Invitations, access credentials, and evaluation licences are personal to the invited participant or authorized organization and may not be shared, sold, or assigned.

Your invitation or program notice identifies the product or feature, eligible participants, access period, supported environment, and any additional testing conditions. It also states any fee, compensation, or other agreed commercial terms before you accept them.

If you participate for an organization, you must have authority to accept the applicable terms for that organization. Only its authorized participants may use the Beta Product within the agreed scope. Participation must comply with applicable law and the eligibility requirements stated for the program.

Program changes and the end of participation are addressed in Sections 10 and 13. An invitation does not promise selection for another program or access to a future commercial release.

Section 2

Evaluation Scope & Pre-Release Status

A Beta Product is a version, service, or feature expressly identified by EMPHOS as beta, early access, preview, pilot, or pre-release. It is supplied for the agreed evaluation and testing purposes and may have incomplete features, limited documentation, compatibility issues, or defects.

• Features, performance, interfaces, file formats, and system requirements may change before a final release.
• Errors may cause interruptions, incorrect results, or loss of test data. Keep backups and use copies of files when testing.
• Test accounts or hosted test environments may be reset or retired as described in the program notice.
• Participation does not guarantee a final release, a particular release date, or inclusion of a tested feature in a commercial product.

Do not rely on a Beta Product for production or business-critical operations unless a separate written pilot agreement expressly authorizes that use and sets out its conditions. For testing that changes files, runs commands, or interacts with external services, use an environment and permissions appropriate to the agreed test.

Where a Beta Product produces AI-generated responses, measurements, analysis, or automated actions, review and verify the results before relying on them. Report unexpected behavior through the program’s support channel.

Section 3

Evaluation Licence & Permitted Use

Subject to this Agreement and the program terms, EMPHOS grants you a limited, non-exclusive, non-transferable, revocable licence to access and use the Beta Product during the authorized period solely for evaluation, testing, and providing feedback.

The licence covers only the users, devices, features, and environments permitted by your invitation. It does not grant commercial deployment, distribution, resale, hosting for third parties, or rights to create derivative versions of the Beta Product. Any broader pilot or business use requires a separate written agreement.

Do not bypass access or evaluation limits, share credentials, remove proprietary notices, or use the program to gain unauthorized access to systems or data. Reverse engineering, extraction of proprietary code or model components, and other restricted activities remain subject to the applicable product terms, third-party licences, and rights provided by law.

EMPHOS and its licensors retain their rights in the Beta Product. Your existing files and materials remain subject to your rights and those of their respective owners. This evaluation licence does not alter a separate paid licence for a released product.

Section 4

Feedback & Issue Reports

4.1 Useful reports

Feedback is voluntary unless a separate program agreement specifies particular evaluation activities. Send suggestions, bug reports, and feature requests through the designated program channel. For a reproducible issue, include:

• The program, product, and build or version.
• Your operating system and relevant environment details.
• The steps taken, expected result, and actual result.
• An error message, redacted screenshot, or minimal test example where useful.

For a suspected security issue, report it privately and stop any testing that could expose another person’s information, disrupt a service, or damage data. Use only accounts, devices, and information you are authorized to test. Participation does not authorize unrestricted security testing.

4.2 Rights in feedback

You grant EMPHOS a worldwide, perpetual, irrevocable, royalty-free, fully paid-up licence to use, reproduce, modify, distribute, and incorporate the suggestions, bug reports, and other feedback you voluntarily provide into its products and services, without an obligation to pay compensation or provide attribution unless separately agreed in writing.

EMPHOS owns the improvements it creates, subject to existing third-party rights. The feedback licence does not transfer ownership of your pre-existing documents, code, intellectual property, or confidential materials. Do not submit material you are not entitled to share.

We may use ordinary product feedback without treating the ideas themselves as confidential, unless separately agreed. Personal information, support attachments, and information protected by a separate confidentiality agreement remain subject to their applicable protections.

Section 5

Confidentiality

5.1 Information covered

Confidential Information means non-public Beta Products and program information disclosed to you that is marked confidential or should reasonably be understood to be confidential. It may include unreleased builds, non-public features, technical documentation, source or model materials, access credentials, test results, benchmarks, and private program communications.

An announced product’s existence or information EMPHOS has made public is not confidential merely because the product also has a beta program. Non-public details provided through that program remain protected.

5.2 Your obligations

• Use Confidential Information only for the authorized evaluation.
• Protect it with reasonable care and restrict access to participants expressly authorized for the program.
• Obtain written permission before disclosing non-public material to others or publishing screenshots, recordings, reviews, benchmarks, or test results that reveal it.
• Promptly notify EMPHOS if you discover loss, unauthorized access, or disclosure of program material.

Do not upload confidential builds, documentation, logs, or other program material to a public repository, sharing service, or third-party AI service without authorization.

5.3 Exceptions and required disclosure

Confidentiality does not cover information you can demonstrate was already lawfully known to you, became public without a breach, was lawfully obtained from a third party without a confidentiality duty, was independently developed without using Confidential Information, or was approved for release in writing.

If disclosure is required by law, disclose only what is required and, where lawful, give EMPHOS prompt notice and reasonable assistance with protective measures. Nothing in this Agreement prevents a legally protected report to a regulator, law-enforcement authority, or other protected recipient.

5.4 Duration and separate NDAs

These confidentiality obligations continue throughout participation and for two years after participation ends. A separate signed non-disclosure agreement continues to govern information within its scope, including any different duration expressly agreed there.

Section 6

Test Data, Diagnostics & Privacy

Personal information is handled under our Privacy Policy and the notices supplied for the program. Beta status does not remove privacy obligations or provide blanket permission to collect additional information.

6.1 Data used for testing

Use synthetic, anonymized, or otherwise suitable test data. Do not provide payment details, credentials, personal information, confidential customer files, or other sensitive material unless the written program scope specifically permits it and you have the required authority and lawful basis.

Written permission to run a test does not replace another person’s consent or other legal requirements. If a business pilot involves EMPHOS processing personal information on your organization’s behalf, the relevant processing arrangements must be agreed before that information is submitted.

6.2 Diagnostics and support submissions

A program may request diagnostic information such as the build version, operating system, error details, or logs relevant to an issue. The program notice explains what is collected, the purpose, recipients, retention, and any choices before collection. We obtain consent where required by law.

Review logs and screenshots before submitting them and remove unrelated personal information or secrets. A report should contain the minimum information needed to reproduce or investigate the problem.

6.3 Local and connected features

Local files are not automatically submitted to EMPHOS simply because you participate in a beta. A support upload or connected feature may transmit information as described for that feature. This Agreement does not grant general permission to inspect your device, upload all local content, or use private files for model training.

Keep your own backups and follow the program’s instructions for exporting test results and ending access. Any hosted-data reset, retention, or deletion arrangements are governed by the program notice, applicable agreements, and privacy law.

Section 7

Participation, Fees & Compensation

Participation is voluntary. It does not create employment, a paid consulting arrangement, a bug-bounty entitlement, or a right to credits, royalties, or other compensation unless EMPHOS separately agrees in writing.

Any fee for access, payment for testing, credit, or other benefit must be stated in the program’s written terms. This Agreement does not itself impose a participation fee or promise a discount, free commercial licence, or future release.

If you purchase early access, the disclosed supply, cancellation, and refund terms apply together with your mandatory consumer rights. A paid product does not lose those protections because it is labelled beta or early access.

Section 8

Pre-Release Warranties & Support

A Beta Product is supplied in its current pre-release condition, on an “as is” and “as available” basis, subject to any express commitments in your program agreement and rights that applicable law does not allow us to exclude.

We do not promise uninterrupted operation, error-free results, compatibility beyond the stated test environment, or availability of a final version. Except for obligations that cannot lawfully be excluded, no additional implied warranty of merchantability, fitness for a particular purpose, title, or non-infringement is given.

Beta support uses the designated program channel. Unless a written program agreement provides otherwise, there is no guaranteed response time or commitment to implement a suggestion or fix every reported issue before the program ends.

Where consumer law gives you rights concerning quality, description, reasonable care, updates, repair, replacement, price reduction, or refund, those rights continue to apply. The pre-release description does not cancel an express promise made for a paid offer.

Section 9

Responsibility & Liability

Use the Beta Product within the agreed evaluation scope, maintain backups, and take reasonable steps to avoid foreseeable loss. Notify EMPHOS of a material defect or incident so that it can be investigated.

For business and organizational evaluations, to the extent permitted by applicable law and subject to any separate written pilot agreement, EMPHOS excludes liability for indirect, incidental, special, consequential, or punitive loss arising from use of or inability to use the Beta Product, including resulting loss of profits or business opportunity.

For consumers, this Agreement does not exclude liability or remedies that consumer law requires, including applicable remedies for defective or misdescribed digital content. Stopping use is an option when you are dissatisfied; it is not your only remedy where the law or your purchase terms provide another.

No term excludes or limits liability for fraud, fraudulent misrepresentation, death or personal injury caused by negligence where such exclusion is prohibited, or any other liability that cannot lawfully be excluded or limited.

Section 10

Ending Participation & Program Changes

You may leave a Beta Program at any time by notifying EMPHOS in writing. EMPHOS may end your participation or a program by written notice, subject to any different notice requirements in a written pilot agreement and applicable law.

We may suspend access immediately to address a material breach, unauthorized disclosure, a security threat, or a legal requirement. Where lawful and practicable, we will explain the reason and provide a contact for questions. A suspension or program closure does not remove refund or other rights that apply to paid access.

A build may expire, be replaced, or require an update during the program. The program notice identifies the evaluation period and any known access deadlines. We will communicate material program changes and any available export or transition steps; migration of beta data to a final release is not guaranteed.

When your evaluation licence ends

• Stop using the affected Beta Product and remove its evaluation copies and access credentials as instructed.
• Return or delete EMPHOS Confidential Information as required by the program or separate NDA, subject to lawful retention obligations.
• Retain your own documents and work where you have the right to do so. Ending a beta does not require deletion of unrelated personal files or a separately licensed released product.
• Continue observing confidentiality and any other obligations intended to survive the end of participation.

The rights already granted in voluntarily submitted feedback continue as described in Section 4. Information EMPHOS holds after participation is handled under the applicable privacy and retention terms.

Section 11

Governing Law & Applicable Rights

This Agreement is governed by the laws of British Columbia and the federal laws of Canada applicable there. Disputes are subject to the courts of British Columbia, except where mandatory law gives you the right to rely on another jurisdiction’s protections or bring a claim in another competent court.

Nothing in this Agreement waives rights, remedies, or protections that cannot be waived under applicable law, or prevents you from raising a concern with a competent regulator.

Section 12

Beta Program Contact

For invitation questions, access issues, feedback, bug reports, or a request to end participation, contact:

Include “BETA PROGRAM” and the product or program name in the subject line to help route your message. Do not include passwords, sign-in codes, private keys, or unrelated confidential data.

Section 13

Agreement Versions & Program Terms

The invitation, this Agreement, and applicable product terms define the evaluation. A separate written pilot agreement or NDA governs the matters it expressly covers. Mandatory law takes priority over conflicting terms.

We may publish an updated version of this Agreement with a new revision date. Material changes affecting an existing program will be communicated through that program, with acceptance obtained where required. Posting a new website date does not by itself replace a separately agreed contract.